Attralus, Inc. is a company that provides Systemic amyloidosis, Biopharmaceutical, Pathology and more. Attralus, Inc. is headquartered in United States California. Attralus, Inc. was founded in 2019. Attralus, Inc. has a total of 29 patents and 1 literature
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Its proprietary...
What is Attralus, Inc.'s official website?
Attralus, Inc.'s official website is http://www.attralus.com.